LPX Lipoxen

TIDMLPX

RNS Number : 2677J

Lipoxen PLC

28 June 2011

28 June 2011

Lipoxen plc

Result of AGM

Lipoxen (AIM: LPX.L), the bio-pharmaceutical company specialising in the development of high-value differentiated biologicals, announces that its Annual General Meeting was held today at 12pm at the London Capital Club, 15 Abchurch Lane, London EC4N 7BW. All resolutions were duly passed.

Enquiries:

 
 Lipoxen plc                                       +44 (0)20 7389 5015 
 M. Scott Maguire, Chief Executive 
  Officer 
 
 Walbrook PR Ltd                                   +44 (0)20 7933 8780 
 Paul McManus (Media Enquiries)                     Mob: 07980 541 893 
                                           paul.mcmanus@walbrookpr.com 
 Paul Cornelius (Investor Enquiries)                Mob: 07866 384 707 
                                         paul.cornelius@walbrookir.com 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGLLFELRSITFIL

Lipoxen (LSE:LPX)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025

Lipoxen (LSE:LPX)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025